Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) EBT: 2019-2024

Historic EBT for Beam Therapeutics (BEAM) over the last 6 years, with Dec 2024 value amounting to -$376.7 million.

  • Beam Therapeutics' EBT fell 16.61% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$421.8 million, marking a year-over-year decrease of 194.01%. This contributed to the annual value of -$376.7 million for FY2024, which is 187.21% down from last year.
  • As of FY2024, Beam Therapeutics' EBT stood at -$376.7 million, which was down 187.21% from -$131.2 million recorded in FY2023.
  • In the past 5 years, Beam Therapeutics' EBT registered a high of -$131.2 million during FY2023, and its lowest value of -$376.7 million during FY2024.
  • For the 3-year period, Beam Therapeutics' EBT averaged around -$256.0 million, with its median value being -$260.2 million (2022).
  • Per our database at Business Quant, Beam Therapeutics' EBT skyrocketed by 49.59% in 2023 and then slumped by 187.21% in 2024.
  • Over the past 5 years, Beam Therapeutics' EBT (Yearly) stood at -$194.6 million in 2020, then tumbled by 90.47% to -$370.6 million in 2021, then grew by 29.80% to -$260.2 million in 2022, then surged by 49.59% to -$131.2 million in 2023, then tumbled by 187.21% to -$376.7 million in 2024.